(Date:12/2/2009)...c. 2 Reportlinker.com announces th...s catalogue: ,, Point of Care Diagnostics ,...Care-Diagnostics.html ,, Provides a complete r...nostics industry ,, Includes market forecasts t... ,, Covers federal regulation of POC testing ,...
(Date:12/2/2009)...Dec. 2 The Washington Post reporte...ording to Coremetrics, a marketing optimization co...onday compared to Cyber Monday 2008. ,, Contras...pas who reported today "Cyber Monday website traff...9%" - said Tiffany Amorosino, COO of Bella Sante. ...
(Date:12/2/2009)...ave metabolic syndrome, study finds , , ...ne isn,t enough to keep overweight college footbal...condition that can lead to heart disease, a new st...Division I colleges and found that two-thirds were...e, a group of conditions that raise the risk for h...
(Date:12/2/2009)... 2 In the wake of the f...inated with a plastics chemical linked to birth de...tely to protect infants and mothers. ,, The Hou...ol A, or BPA, in food and beverage containers. The... Rep. Edward Markey of Massachusetts, would protec...
(Date:12/2/2009).... 2 Independence Blue Cross (IBC) ...ith Lincoln Financial Group. IBC will be the prima...10,000 Lincoln Financial Group employees, retirees...oln plan offerings will include the PPO option and...I speak for all of us at Independence Blue Cross w...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3Health News:Oversized College Football Players May Face Heart Risks 2Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3(Date:12/2/2009)... ALTO, Calif., Dec. 2 Va...mber 25, 2009, Varian, Inc. filed with the U.S. Se... on Form 10-K for the fiscal year ended October 2,... the Company,s web site at www.varianinc.com, by c... on "10-K" in the table shown. Stockholders may r...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com...ailable in its catalogue: ,, Pharmaceutical C..., http://www.reportlinker.com/p0164248/Pharmace...ds.html ,, Global pharma industry faces nume...ion in generic markets, rising cost of new product...
(Date:12/2/2009)... PARK, Ill., Dec. 2 Abbo...ing a vast array of microorganisms has been named ...st magazine. A panel of expert judges evaluated ...rmine the year,s top innovations, with the winners...online at www.the-scien t ist.com/top10innovat...
Breaking Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 1AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 2AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 3First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 1First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 2First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 3Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter 5865 1Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter 5865 2...ences, Inc. (Nasdaq: RDEA ) today announced that ...ty of the Company,s non-nucleoside reverse,transcr...st the,human-immunodeficiency virus (HIV), the kno...nt strains., The data was presented at the 15th A... Infections (CROI) in Boston., The data showed th...
...and lipid effects between REYATAZ/ritonavir and...CETON, N.J., Feb. 6 Bristol-Myers Squibb,Company ...TLE study, in which,300 mg of once-daily REYATAZ(R...vir (REYATAZ/r) showed similar antiviral efficacy ...mg (lopinavir/r) in previously untreated,adult HIV...
Other Medicine Technology:Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 2Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 3CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 2CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 3CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 4CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 5CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 6...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: